Checking IMVT unusual options activity helps you spot when traders are making outsized bets on Immunovant Inc before the broader market catches on. Immunovant Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor IMVT unusual options activity today and surface the prints that deserve a second look.
Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching IMVT unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking IMVT unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and IMVT unusual options flow data becomes especially valuable around earnings, product launches, and macro events.
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of myasthenia gravis and thyroid eye disease, as well as completed initiation of Phase II clinical trials for the treatment of warm autoimmune hemolytic anemia. The company was incorporated in 2018 is headquartered in New York, New York. Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd.
Catalysts rarely arrive without a footprint, and IMVT unusual options activity is often where that footprint shows up first. Our scanner tracks Immunovant Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at IMVT unusual options volume on the call side or chasing put sweeps, Immunovant Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.
